SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,313,405 | +5.6% | 439,807 | -0.2% | 0.09% | +11.1% |
| Q2 2023 | $50,488,547 | -16.4% | 440,871 | +0.6% | 0.08% | -18.2% |
| Q1 2023 | $60,392,420 | -33.3% | 438,166 | -17.5% | 0.10% | -10.0% |
| Q4 2020 | $90,532,000 | +16.6% | 531,012 | -4.0% | 0.11% | 0.0% |
| Q3 2020 | $77,673,000 | -11.4% | 553,109 | +1.2% | 0.11% | -21.4% |
| Q2 2020 | $87,667,000 | +77.9% | 546,757 | +8.5% | 0.14% | +32.1% |
| Q1 2020 | $49,275,000 | -26.6% | 503,731 | -3.1% | 0.11% | -9.4% |
| Q4 2019 | $67,087,000 | +39.0% | 519,895 | -18.8% | 0.12% | +28.6% |
| Q3 2019 | $48,253,000 | – | 640,639 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |